- Blog
- Homepage
-
Understanding US Trucking Sentiment & Positioning Ahead of Earnings
As the trucking industry prepares to release its earnings reports for the first quarter, investors are closely monitoring sentiment and positioning within the sector. According to a recent report by UBS, there is a mix of optimism and caution among investors, with some leaning towards bullish views while others remain cautious due to valuation concerns.…
-
CTA’s Maintain Short Positioning in UST Futures Despite Recent Unwinds
CTAs are maintaining their large short positioning in UST futures, according to the latest tracker from UBS Securities and Treasury (UBS S&T). While there have been some unwinds of shorts in the 10y and 20y buckets, the majority of CTA positions remain focused on the short side. The desk’s current positioning shows a slight shift…
-
Liquidity Recovery and Flow Analysis: A Sign of Market Stability?
Liquidity is a crucial aspect of any financial market, as it determines the ease with which buyers and sellers can transact. In recent times, liquidity has been a concern for many investors due to geopolitical uncertainty and other factors. However, recent data suggests that liquidity may be recovering, which could be a positive sign for…
-
Market Rebound Continues: High Beta Stocks Lead the Charge
The market continues to show signs of strength as we head into the middle of the week, with high beta stocks leading the charge. According to Goldman’s mid-day wrap, the NDX is on track to trade higher for its 10th consecutive session, and the SPX is trading a touch below its ATHs (6978 ATH close…
-
Aspiravi Therapeutics (ASPI) Receives a Buy Rating from Canaccord with $11 Price Target
Aspiravi Therapeutics, Inc. (NASDAQ: ASPI), a biotechnology company focused on developing innovative treatments for rare and neglected diseases, has received a Buy rating from Canaccord with a $11 price target. The ratings reiteration comes after the company filed its 10K and held a call with investors. According to Canaccord analysts, Aspiravi’s strong pipeline of drug…
-
United States and Iran Propose Suspension of Nuclear Activities for 20 Years
The United States and Iran have proposed a historic agreement that would see both countries suspend their nuclear activities for a period of 20 years. According to sources close to the negotiations, the proposal was made during recent talks between the two nations in an effort to find a peaceful solution to the ongoing conflict.…
-
US Thematic Basket Movers: S&P Recoups Iran Losses
The S&P 500 has rebounded from the losses incurred due to the conflict between the US and Iran, with optimism building around a potential agreement between the two nations. The Middle East Resilient basket continues to face challenges, down by 1.4%, while the Airlines sector has seen a significant bounce, up by 5.6%. This is…
-
Investor Sentiment Shifts as Oil Prices Soar: A Look into the Future of Energy
As we begin 2026, investors are shifting their expectations for oil prices, according to a recent survey by Bank of America Merrill Lynch. The findings indicate that on a weighted average basis, FMS investors anticipate oil to trade at $84/bbl by the end of the year, marking a 38% increase from the starting price of…
-
US Treasuries Market Shows Signs of Strength Amidst Geopolitical Tensions
The US Treasuries market has shown signs of strength in recent days, despite ongoing geopolitical tensions. The yield on the 10-year Treasury note is currently trading at 4.29%, which is a full 0.25-0.75 basis points higher than the previous day’s close. Equities are also higher by another 0.2% today, with the S&P 500 index reaching…
-
Market Sentiment Shifts as Geopolitical Uncertainty Fades
As geopolitical tensions subside, market sentiment is shifting gears. While some investors remain cautious due to the lingering macro uncertainty, others are becoming more optimistic about the near-term outlook. The micro picture continues to improve, with equity beta returns stabilizing and technical indicators remaining supportive. However, strategists advise caution when it comes to taking large…
IBAFIN 